The rabies treatment market has been primarily characterized by the use of post-exposure prophylaxis, involving a series of vaccinations and immune globulins, administered immediately after exposure to the virus. This approach, while effective, is not without its challenges – limited accessibility and high costs of treatments in certain regions combine...
Discover more insights